Maxine X. Patel, MD
- 5Articles
- 40.5KReads1
- 2004–2015Active
- 13Collaborators
- 238Citations2
About
Maxine X. Patel, MD, has published extensively on topics related to schizophrenia, schizoaffective disorders, and neurology. Patel's work includes studies on psychotropic medication use in emotionally unstable personality disorder, dose-response relationships and receptor occupancy of antipsychotics such as quetiapine and aripiprazole, and patient adherence to antipsychotic treatments. Patel has contributed to research on long-acting injectable antipsychotics, including risperidone, with a focus on clinical monitoring and therapeutic drug management. Collaborations frequently include co-authors Anna Sparshatt, David Taylor, Shitij Kapur, Anthony S. David, and Carol Paton.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
